Advertisement

International Journal of Public Health

, Volume 60, Supplement 1, pp 23–30 | Cite as

Cost-effectiveness analysis of salt reduction policies to reduce coronary heart disease in Syria, 2010–2020

  • Meredith L. WilcoxEmail author
  • Helen Mason
  • Fouad M. Fouad
  • Samer Rastam
  • Radwan al Ali
  • Timothy F. Page
  • Simon Capewell
  • Martin O’Flaherty
  • Wasim Maziak
Original Paper

Abstract

Objectives

This study presents a cost-effectiveness analysis of salt reduction policies to lower coronary heart disease in Syria.

Methods

Costs and benefits of a health promotion campaign about salt reduction (HP); labeling of salt content on packaged foods (L); reformulation of salt content within packaged foods (R); and combinations of the three were estimated over a 10-year time frame. Policies were deemed cost-effective if their cost-effectiveness ratios were below the region’s established threshold of $38,997 purchasing power parity (PPP). Sensitivity analysis was conducted to account for the uncertainty in the reduction of salt intake.

Results

HP, L, and R + HP + L were cost-saving using the best estimates. The remaining policies were cost-effective (CERs: R = $5,453 PPP/LYG; R + HP = $2,201 PPP/LYG; R + L = $2,125 PPP/LYG). R + HP + L provided the largest benefit with net savings using the best and maximum estimates, while R + L was cost-effective with the lowest marginal cost using the minimum estimates.

Conclusions

This study demonstrated that all policies were cost-saving or cost effective, with the combination of reformulation plus labeling and a comprehensive policy involving all three approaches being the most promising salt reduction strategies to reduce CHD mortality in Syria.

Keywords

Cost-effectiveness Salt reduction Coronary heart disease CHD Syria Eastern Mediterranean Region EMR 

Notes

Acknowledgments

This work was funded by the EU FP7 grants for the MedCHAMPS project (MEDiterranean studies of Cardiovascular disease and Hyperglycaemia: Analytical Modelling of Population Socio-economic transitions) and the RESCAP-MED project (RESearch CApacity for Public health in the MEDiterranean).

References

  1. Al Ali R, Rastam S, Fouad FM, Mzayek F, Maziak W (2011) Modifiable cardiovascular risk factors among adults in Aleppo, Syria. Int J Public Health 56(6):653–662PubMedCrossRefGoogle Scholar
  2. Appel LJ, Angell SY, Cobb LK, Limper HM, Nelson DE, Samet JM et al (2012) Population-wide sodium reduction: The bumpy road from evidence to policy. Ann Epidemiol 22(6):417–425PubMedCrossRefGoogle Scholar
  3. Asaria P, Chisolm D, Mathers C, Ezzati M, Beaglehole R (2007) Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 370:2044–2053PubMedCrossRefGoogle Scholar
  4. Briggs A, Sculpher M, Buxton M (1994) Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 3(2):95–104PubMedCrossRefGoogle Scholar
  5. Brundtland GH, Glinka E, zur Hausen H, Luiz d’Avila R (2013) Open letter: let us treat patients in Syria. Lancet 382(9897):1019–1020PubMedCrossRefGoogle Scholar
  6. Capewell S, Critchley J, Unal B (2007). IMPACT, a validated, comprehensive coronary heart disease model: Overview and technical appendices. Accessed 01 November 2013. Available at: http://www.liv.ac.uk/PublicHealth/sc/bua/IMPACT_Model_%20Appendices_May_2007.pdf
  7. Cappuccio F, Capewell S, Lincoln P, McPherson K (2011) Policy options to reduce population salt intake. BMJ 343:d4995PubMedCrossRefGoogle Scholar
  8. Central Bureau of Statistics (CBS 2011) Central Bureau of Statistics. Available at: http://www.cbssyr.org/index-EN.htm
  9. Cobiac L, Vos T, Veermen L (2010) Cost-effectiveness of interventions to reduce dietary salt intake. Heart 85:1920–1925CrossRefGoogle Scholar
  10. Hooper L, Bartlett C, Davey Smith G, Ebrahim S (2004) Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database Syst Rev. Issue 1. doi: 10.1002/14651858.CD003656.pub2. (Art No: CD003656)
  11. Fidan D, Unal B, Critchley J, Capewell S (2007) Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000–2010. QJM 100(5):277–289PubMedCrossRefGoogle Scholar
  12. He F, MacGregor G (2004). Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. Issue 1. doi: 10.1002/14651858.CD004937. (Art No: CD004937)
  13. Mason H, Shoaibi A, Ghandour R, O’Flaherty M, Capewell S, Khatib S et al (2014) A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries. PLoS One 9(1):e84445. doi: 10.1371/journal.pone.0084445 PubMedCentralPubMedCrossRefGoogle Scholar
  14. Maziak W, Ward KD, Mzayek F, Rastam S, Bachir ME, Fouad MF et al (2005) Mapping the health and environmental situation in informal zones in Aleppo, Syria: report from the Aleppo household survey. Int Arch Occup Environ Health 78(7):547–558PubMedCrossRefGoogle Scholar
  15. Maziak W, Rastam S, Mzayek F, Ward KD, Eissenberg T, Keil U (2007) Cardiovascular health among adults in Syria: a model from developing countries. Ann Epidemiol 17(9):713–720PubMedCentralPubMedCrossRefGoogle Scholar
  16. Mohan S, Campbell NR, Willis K (2009) Effective population-wide public health interventions to promote sodium reduction. Can Med Assoc J 181(9):605–609CrossRefGoogle Scholar
  17. Murray CJ, Lopez AD (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349(9061):1269–1276PubMedCrossRefGoogle Scholar
  18. Murray C, Lauer J, Hutubessy R, Neissen L, Tomijima N, Rodgers A et al (2003) Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis in reduction of cardiovascular-disease risk. Lancet 361:717–725PubMedCrossRefGoogle Scholar
  19. Musaiger AO, Al-Hazzaa HM (2012) Prevalence and risk factors associated with nutrition-related noncommunicable diseases in the Eastern Mediterranean region. Int J Gen Med 5:199–217PubMedCentralPubMedCrossRefGoogle Scholar
  20. Rastam S, Al Ali R, Maziak W, Mzayek F, Fouad FM, O’Flaherty M, Capewell S (2012) Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006. BMC Public Health 12:754PubMedCentralPubMedCrossRefGoogle Scholar
  21. Selmer R, Kristiansen I, Haglerød A, Graff-Iversen S, Larsen H, Meyer H et al (2000) Cost and health consequences of reducing the population intake of salt. J Epidemiol Community Health 54:697–702PubMedCentralPubMedCrossRefGoogle Scholar
  22. Smith-Spangler C, Juusola J, Enns E, Owens D, Garber A (2010) Population strategies to decrease sodium intake and the burden of cardiovascular disease. Ann Intern Med 152:481–487PubMedCrossRefGoogle Scholar
  23. Unal B, Critchley JA, Fidan D, Capewell S (2005) Life-years gained from modern cardiological treatments and population risk factors changes in England and Wales, 1981–2000. Am J Public Health 95(1):103–108PubMedCentralPubMedCrossRefGoogle Scholar
  24. United Nations (UN) (2011) Department of Economics and Social Affairs. Accessed 27 January 2011. Available at: http://www.un.org/esa/population/
  25. United Nations (UN) (2013) Purchasing power parities (PPP) conversion factor, local currency unit to international dollar. United Nations Statistics Division. Accessed 10 November 2013. Available at: http://data.un.org/Data.aspx?d=MDG&f=seriesRowID:699
  26. Wang G, Labarthe D (2011) The cost-effectiveness of interventions designed to reduce sodium intake. J Hypertens 29:1693–1699PubMedCrossRefGoogle Scholar
  27. World Health Organisation (WHO) (2002) World Health Report 2002Google Scholar
  28. World Health Organization (WHO) (2003a) Noncommunicable disease. STEPwise surveillance. Syrian Arab Republic Report. Available at: http://www.emro.who.int/ncd/pdf/stepwise_syria.pdf
  29. World Health Organization (WHO) (2003b) Making choices in health: WHO guide to cost-effectiveness analysis. Edited by Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, Murray CJL. Geneva: World Health OrganizationGoogle Scholar
  30. World Health Organization (WHO) (2004) WHO Global Health Observatory. Accessed 10 November 2013. Available at: http://apps.who.int/ghodata/
  31. World Health Organization (WHO) (2005) Preventing chronic diseases: a vital investment. WHO global report. Geneva: World Health OrganizationGoogle Scholar
  32. World Health Organization (WHO) (2008) The global burden of disease: 2004 updateGoogle Scholar
  33. World Health Organization (WHO) (2010) Creating an enabling environment for population-based salt reduction strategies: report of a joint technical meeting held by WHO and the Food Standards Agency, United KingdomGoogle Scholar
  34. World Health Organization (WHO) (2011) Global status report on non-communicable diseases 2010. World Health Organization, GenevaGoogle Scholar
  35. World Health Organisation (WHO) (2013) Choosing interventions that are cost effective (WHO-CHOICE: Threshold values for intervention cost effectiveness by region. Accessed 10 November 2013. Available at: http://www.who.int/choice/costs/CER_levels/en/index.html
  36. World Health Organization (WHO) (2013a) Middle Eastern Region: Syrian Arab Republic statistics summary (2002-present). Global Health Observatory Data Repository. Accessed 01 Novemeber 2013. Available at: http://apps.who.int/gho/data/node.country.country-SYR?lang=en
  37. World Health Organization (WHO) (2013b) Syrian Arab Republic, Jordan, Lebanon, Iraq: Situation Report. Issue No. 16. 21 June–9 July, 2013. Accessed 01 November 2013. Available at: http://www.emro.who.int/images/stories/syria/Regional_situation_report_no_16.pdf
  38. World Health Organization (WHO) (2013c) Health impact of the crisis in the Syrian Arab Republic. Emergency preparedness and humanitarian action, 2013. Accessed 01 November 2013. Available at: http://www.emro.who.int/emergency/eha-news/syria-sitrep.html
  39. World Health Organization (WHO) (2013d) Syrian Arab Republic, Jordan, Lebanon, Iraq: Monthly Situation Report. Issue No. 18. 10 August–10 September, 2013. Accessed 01 November 2013. Available at: http://www.emro.who.int/images/stories/syria/documents/Syria_crisis_SitRep_WHO_18_01_Oct.pdf
  40. World Health Organization (WHO) (2013e) Syrian Arab Republic, Jordan, Lebanon, Iraq: monthly situation report (Annex). Issue No. 18. 10 August–10 September, 2013. Accessed 01 November 2013. Available at: http://www.emro.who.int/images/stories/syria/documents/Annex_Sitrep_WHO_18__01-Oct_.pdf

Copyright information

© Swiss School of Public Health 2014

Authors and Affiliations

  • Meredith L. Wilcox
    • 1
    Email author
  • Helen Mason
    • 2
  • Fouad M. Fouad
    • 3
    • 4
  • Samer Rastam
    • 4
  • Radwan al Ali
    • 4
  • Timothy F. Page
    • 5
  • Simon Capewell
    • 6
  • Martin O’Flaherty
    • 6
  • Wasim Maziak
    • 1
    • 4
  1. 1.Department of EpidemiologyFlorida International UniversityMiamiUSA
  2. 2.Yunus Centre for Social Business and HealthGlasgow Caledonian UniversityGlasgowUK
  3. 3.American University of BeirutBeirutLebanon
  4. 4.Syrian Centre for Tobacco StudiesAleppoSyria
  5. 5.Department of Health Policy and ManagementFlorida International UniversityMiamiUSA
  6. 6.Department of Public Health and PolicyUniversity of LiverpoolLiverpoolUK

Personalised recommendations